










 


    Peony Yu | FibroGen Inc | ZoomInfo.com


Chief Medical Officer of FibroGen (NASDAQ:FGEN), Yu K Peony, sells 5,000 shares worth 4,900








































Stay Connected

Latest Posts in RSS

BusinessEntertainmentFeatured NewsFeatured Press ReleaseFinanceHealthLifestyleNationNon FirstPageOriginalPress ReleaseReviewShoppingSportsStocksTechnologyTravelWorld


Latest Comments in RSS


 / 













EmpoweredNews
World News Summary Helping You Stay Informed









Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping




Our Writers
About Us
Privacy Policy
Contact Us
Advertise
Press Releases
















Chief Medical Officer of FibroGen (NASDAQ:FGEN), Yu K Peony, sells 5,000 shares worth $164,900
According to FibroGen's most recent Form 4 filing with the SEC dated Jul 11 07:38 PM, company Chief Medical Officer, Yu K Peony disclosed selling 5,000 shares at a cost of $32.98. At the time of this transaction (Jul 10), this trade was worth $164,900 in total. As of Jul 10, Yu K Peony now owns 216,507 shares in total worth about $7,047,302.85. 
For the last few recent trades made by FibroGen (NASDAQ:FGEN) Chief Medical Officer, Yu K Peony, we have the following information:




SEC Form 4 filing: Jun 14: Sold 3,721 shares at the rate of $28.95 per share. Total worth of this trade was $107,723. Total number of shares owned as of Jun 14 were 221,507
SEC Form 4 filing: Mar 14: Sold 7,851 shares at the rate of $25.41 per share. Total worth of this trade was $199,458. Total number of shares owned as of Mar 14 were 231,046
SEC Form 4 filing: Dec 14: Sold 2,344 shares at the rate of $20.65 per share. Total worth of this trade was $48,404. Total number of shares owned as of Dec 14 were 207,448




					Posted by  



George Daniels 

					
					on Tuesday July 11 2017, 7:51 PM EDT. 

All trademarks acknowledged. 
Filed under Stocks.

	Comments and Trackbacks closed.	
 Follow responses: 
RSS 2.0




Comments are closed


 Latest News 
Former 10% Owner of Internap Corporation (NASDAQ:INAP), Park West Asset Management Llc, sells 2,250,000 shares worth $8,723,250
Chairman of the Board and CEO of Salesforce (NYSE:CRM), Benioff Marc, sells 10,000 shares worth $908,911
Pres., Sales & Cust. Success of Salesforce (NYSE:CRM), Martinez Maria, sells 10,000 shares worth $920,007
Chief Executive Officer of Salem Media Group (NASDAQ:SALM), Atsinger Edward G Iii, sells 483 shares worth $3,598
SVP & Chief Accounting Officer of CoBiz Financial Inc (NASDAQ:COBZ), Dumlao Troy, sells 493 shares worth $8,923
EVP & Chief Operations Officer of CoBiz Financial Inc (NASDAQ:COBZ), Dalton Richard J, sells 10,000 shares worth $178,000
CEO, Cobiz Bank of CoBiz Financial Inc (NASDAQ:COBZ), Page Scott, sells 3,530 shares worth $62,093
SVP, Global Sales of NeoPhotonics Corporation (NYSE:NPTN), Sitler Benjamin Lee, sells 33,400 shares worth $282,016
Director of NeoPhotonics Corporation (NYSE:NPTN), Sophie Michael J, sells 4,000 shares worth $33,784
President and CEO of Skyworks Solutions (NASDAQ:SWKS), Griffin Liam, sells 8,056 shares worth $848,390

 


News Categories 
Business (7)

Stocks (15,644)



Entertainment (1,297)

Featured News (3,486)

Featured Press Release (253,704)

Finance (309)

Health (653)

Lifestyle (19)

Nation (90)

Non FirstPage (2)

Original (47)

Press Release (17)

Review (1)

Shopping (267)

Sports (613)

Technology (194)

Travel (286)

World (1,367)


  Featured Press Releases 
Global control valve market is expected to grow at a CAGR of 7.6% from 2017 to 2025
Outlook of Asia-Pacific Poly Aluminium Chloride – Product Type Market Industry – Report on – Markets Trend, Cost Structure, Share, Demand & Supply
Medium Silica Zeolite Global and China Market by key players as BASF (Germany), Zeochem AG (US), Tosoh Corporation (US) forecast to 2022
Commercial Airport Lighting 2017 Global Market Expected to Grow at CAGR 7.69 % and Forecast to 2019
Global Plasma Therapy Market is expected to grow at a CAGR of 13.5% from 2017 to 2025
Asia-Pacific Pasta Sauce Market Industry 2022 Overview, in-Depth Analysis, Forecasts, Applications, Shares & Insights
Global Rice Protein Market Research Report 2017-2022
Asia-Pacific Passenger Information System Market- Industry Analysis, Size, Share, Growth, Trends, Competitive Landscape and Forecast To 2022
2017-2022 Marine Biotechnology Market Global (India, United States, china) Detailed Analysis Research Report
Asphalt Pavers Market Set to Witness Steady Growth through (2015-2025)







Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping
 

About Us
Contact Us
Privacy Policy
Advertise
Press Releases
Terms Of Service
 
Log in 















Insider Trading - Yu K Peony - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Yu K Peony





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-12-14Sale
2016-12-166:52 pm
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,344
$20.65
$48,404
207,448(Direct)
View


2016-09-14Sale
2016-09-156:51 pm
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,345
$18.66
$43,758
206,502(Direct)
View


2016-06-10Sale
2016-06-147:25 pm
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,344
$17.96
$42,098
210,257(Direct)
View


2016-05-16Sale
2016-05-185:56 pm
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
6,107
$17.6
$107,483
214,011(Direct)
View


2015-12-10Sale
2015-12-118:41 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
1,093
$28.96
$31,653
176,595(Direct)
View


2015-11-25Sale
2015-11-307:28 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
5,000
$30
$150,000
183,001(Direct)
View


2015-11-17Sale
2015-11-188:22 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
5,000
$28
$140,000
183,345(Direct)
View


2015-11-09Sale
2015-11-106:30 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
5,000
$25.61
$128,075
190,404(Direct)
View


2015-10-19Sale
2015-10-216:13 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
5,000
$24
$120,000
192,904(Direct)
View


2015-10-15Sale
2015-10-167:02 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
5,000
$21.46
$107,300
200,404(Direct)
View


2015-09-10Sale
2015-09-147:40 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
1,093
$27.84
$30,430
202,904(Direct)
View


2015-07-06Sale
2015-07-077:12 pm
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
5,381
$22.69
$122,097
207,254(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-01Tax Withholding
2016-12-028:46 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
1,410
$20.55
209,792(Direct)
View


2016-11-08Exercise
2016-11-088:03 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,000
$3.5
211,202(Direct)
View


2016-11-08Exercise
2016-11-088:03 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,700
$5.95
211,202(Direct)
View


2016-11-08Exercise
2016-11-088:03 pm
N/A2021-06-07
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,000
$3.5
211,202(Direct)
View


2016-11-08Exercise
2016-11-088:03 pm
N/A2022-06-27
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
2,700
$5.95
211,202(Direct)
View


2016-09-01Tax Withholding
2016-09-027:43 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
1,410
$17.33
208,847(Direct)
View


2016-06-01Tax Withholding
2016-06-035:55 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyChief Medical Officer
1,410
$18.89
212,601(Direct)
View


2016-03-03Tax Withholding
2016-03-046:31 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
3,660
$18.77
218,729(Direct)
View


2016-02-22Option Award
2016-02-249:23 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
35,294
$0
222,389(Direct)
View


2016-02-22Option Award
2016-02-249:23 pm
N/A2026-02-22
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
60,000
$19.39
222,389(Direct)
View


2016-02-05Exercise
2016-02-097:32 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
6,000
$3.5
187,095(Direct)
View


2016-02-05Exercise
2016-02-097:32 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
4,500
$5.95
187,095(Direct)
View


2016-02-05Exercise
2016-02-097:32 pm
N/A2021-06-07
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
6,000
$3.5
187,095(Direct)
View


2016-02-05Exercise
2016-02-097:32 pm
N/A2022-06-27
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
4,500
$5.95
187,095(Direct)
View


2015-12-01Tax Withholding
2015-12-038:36 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
657
$29.88
177,688(Direct)
View


2015-09-01Tax Withholding
2015-09-038:58 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
657
$22.84
203,997(Direct)
View


2015-06-01Tax Withholding
2015-06-027:39 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
657
$17.5
210,035(Direct)
View


2015-05-14Tax Withholding
2015-05-188:30 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
2,712
$21.39
210,692(Direct)
View


2015-05-14Exercise
2015-05-188:30 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
4,000
$2.9
210,692(Direct)
View


2015-05-14Exercise
2015-05-188:30 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
4,000
$3.5
210,692(Direct)
View


2015-05-14Exercise
2015-05-188:30 pm
N/A2020-06-09
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
4,000
$2.9
210,692(Direct)
View


2015-05-14Exercise
2015-05-188:30 pm
N/A2021-06-07
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
4,000
$3.5
210,692(Direct)
View


2015-03-04Option Award
2015-03-177:47 pm
N/AN/A
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
32,068
$0
203,068(Direct)
View


2015-03-04Option Award
2015-03-177:47 pm
N/A2025-03-04
Fibrogen Inc
FGEN
Yu K PeonyVP, Clinical Development
64,136
$29.66
203,068(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sat, 29 Jul 2017 03:24:06 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  








 

K. Peony Yu's involvement in venture capital (via Fibrogen Inc)































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/people/210191-yu-k-peonysection=people&subsection=detail&id=210191




			Search deals by company name, industry, location, investors...			
			




SEARCH


K. PeonyYuGet alertedif K. Peony Yu gets funded!K. Peony YuFibrogen Inc - Executive OfficerDeals involving K. Peony Yu$120,000,000 raised with Fibrogen Inc on April, 2017$167,700,000 raised with Fibrogen Inc on January, 2015$20,000,000 raised with Fibrogen Inc on December, 2014Please note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Some of the profile information was collected using the Crunchbase API. For more details on the profile, please check K. Peony Yu on Crunchbase.Inaccurate Data? Help us improve WhoGotFunded: post a comment!


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












YU K PEONY Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      YU K PEONY
                    

•   SAN FRANCISCO, CA
                      
How do I update this listing?




                                             YU K Peony is based out of San Francisco.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from YU K PEONY, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




yu k peony


C/O FIBROGEN, INC.

SAN FRANCISCO
CA
                                                        
                                                    94158









Recent SEC Filings




4 filed on 07/11/2017
4 filed on 06/16/2017
4 filed on 06/08/2017
4 filed on 06/02/2017
4 filed on 05/12/2017
4 filed on 04/27/2017
4 filed on 03/16/2017
4 filed on 03/08/2017
4 filed on 01/12/2017
4 filed on 12/16/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free






















K. Peony Yu - Chief Medical Officer at FibroGen, Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





K. Peony Yu
Chief Medical Officer at FibroGen, Inc.



Overview
Relationships Paths
Career History 


K. Peony Yu
Chief Medical Officer at FibroGen, Inc.



 Overview



Age



55
                                  (Born 1962)
                                              




Number of Relationships



                This person is connected to 643 people.
              






 Relationships
              See Details




Thomas Byron Neff

Founder at FibroGen, Inc.




Patrick Hugh Edward O'Connor

Head of Global Exchange Traded Funds at Franklin Advisers, Inc.





Kenneth Allan Lewis

Chief Financial Officer at Franklin Advisers, Inc.




Gregory Eugene Johnson

Chief Executive Officer at Franklin Templeton Investments





Jennifer M. Johnson

President & Chief Operating Officer at Franklin Templeton Investments




Craig S. Tyle

Chief Legal Officer at Franklin Advisers, Inc.





T. Anthony Coffey

Vice President & Portfolio Manager, Franklin Templeton Solutions at Franklin Advisers, Inc.




Lynda A. Szczech

Executive Director, Clinical Development at FibroGen, Inc.





Pat Cotroneo

Vice President, Finance & Chief Financial Officer at FibroGen, Inc.




Kin Hung Yu

Chief Medical Officer at FibroGen, Inc.







See 633 more listings with RelSci Professional.

Start My Free Trial ➤








See 633 More 


 


 Paths to K. Peony Yu



            K. Peony Yu          




 You



 Connections via Relationship Science



 K. Peony Yu






Sync your contacts to see how you can connect with K. Peony Yu.

Start My Free Trial ➤








See  More 


 


 Career History



Chief Medical Officer

                                    Current                


FibroGen, Inc.


                  FibroGen, Inc. operates as a science-based biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.                





 Other Affiliations




              K. Peony Yu is affiliated with
                            FibroGen, Inc..
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤














FibroGen Inc (FGEN.OQ)  Insider Trading | Reuters.com



























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States


















Insider Trading: FibroGen Inc (FGEN.OQ)





Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				FGEN.OQ on NASDAQ Stock Exchange Global Select Market


				34.25USD
28 Jul 2017





				    Change	(% chg)


		    
						    $0.55


					            (+1.63%)
					        






Prev Close

$33.70


Open

$33.60




Day's High

$34.65


Day's Low

$33.60




Volume

66,008


Avg. Vol

146,826




52-wk High

$35.80


52-wk Low

$15.60


















Yu (K Peony)










Trading Date


Type


Shares Traded


Price


Shares Held



9 Jul 2017

				Sell
5,000
$32.98
216,507


13 Jun 2017

				Sell
3,721
$28.95
221,507


5 Jun 2017

				Sell
829
$29.05
225,228


31 May 2017

				Sell
1,410
$27.60
226,057


9 May 2017

				Sell
1,300
$26.97
226,046


9 May 2017

				Sell
3,700
$26.17
226,046


24 Apr 2017

				Buy
5,000
$14.58
231,046


24 Apr 2017

				Sell
5,000
$28.00
231,046


13 Mar 2017

				Sell
4,651
$25.13
231,046


13 Mar 2017

				Sell
3,200
$25.80
231,046


7 Mar 2017

				Buy
41,176
$0.00
238,897


5 Mar 2017

				Sell
4,727
$25.35
238,897


9 Jan 2017

				Sell
5,000
$23.56
202,448


13 Dec 2016

				Sell
2,344
$20.65
207,448


30 Nov 2016

				Sell
1,410
$20.55
209,792


7 Nov 2016

				Buy
2,700
$5.95
211,202


7 Nov 2016

				Buy
2,000
$3.50
211,202


13 Sep 2016

				Sell
2,345
$18.66
206,502


31 Aug 2016

				Sell
1,410
$17.33
208,847


9 Jun 2016

				Sell
2,344
$17.96
210,257


31 May 2016

				Sell
1,410
$18.89
212,601


15 May 2016

				Sell
6,107
$17.60
214,011


2 Mar 2016

				Sell
3,660
$18.77
218,729


21 Feb 2016

				Buy
35,294
$0.00
222,389


4 Feb 2016

				Buy
4,500
$5.95
187,095




Previous

        Page 1 of 2
	
		 Next










					Institutional Holders





% Shares Owned:
47.66%


# of Holders:
215


Total Shares Held:
33,338,607


3 Mo. Net Change: 

1,085,545



# New Positions:
4


# Closed Positions:
3


# Increased Positions:
21


# Reduced Positions:
13


# Net Buyers:

8









					Officers & Directors





Name
Age
Since
Current Position




							Thomas Neff

62


                                Chairman of the Board, Chief Executive Officer, Founder




							Pat Cotroneo

53
2008

                                Chief Financial Officer, Vice President - Finance




							Frank Valone

66
2016

                                Senior Fellow, Clinical Development




							K. Peony Yu

54
2016

                                Chief Medical Officer




							Jeffrey Edwards

56
2015

                                Independent Director




							Jeffrey Henderson

52
2015

                                Independent Director




							Thomas Kearns

80
2016

                                Independent Director




							Kalevi Kurkijarvi

65
2013

                                Independent Director




							Rory Riggs

64
2013

                                Independent Director




							Roberto Rosenkranz

67
2010

                                Independent Director




							Jorma Routti

78
2013

                                Independent Director




							James Schoeneck

59
2013

                                Independent Director




							Julian Stern

92
2013

                                Independent Director




							Toshinari Tamura

73
2013

                                Independent Director




















Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research




















